These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1145920)

  • 1. Serum proteins in prostatic cancer. II. Effect on in vitro cell-mediated immunologic responsiveness.
    Ablin RJ; Guinan PD; Bruns GR; Sadoughi N; Bush IM
    Urology; 1975 Jul; 6(1):22-9. PubMed ID: 1145920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Migration-inhibitory effect of serum from patients with prostatic cancer.
    Ablin RJ; Bruns GR; Guinan PD; Bush IM
    Oncology; 1974; 30(5):423-8. PubMed ID: 4142651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in host responsiveness in patients with prostatic cancer following cryosurgery or transurethral resection.
    Ablin RJ; Bruns GR; Guinan PD; Sadoughi N; Sheik HA; Bush IM
    Am Surg; 1977 Mar; 43(3):144-50. PubMed ID: 320926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective cellular immunity in renal failure: depression of reactivity of lymphocytes to phytohemagglutinin by renal failure serum.
    Newberry WM; Sanford JP
    J Clin Invest; 1971 Jun; 50(6):1262-71. PubMed ID: 5578233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunocompetent cells in man. II. Existence of distinct populations of circulating lymphocytes capable of responding to stimulation by phytohemagglutinin, antigen, antilymphocyte serum and allogeneic lymphocytes.
    Wu AS; Algom D; Richter M
    Pathol Microbiol (Basel); 1974; 41(1):1-10. PubMed ID: 4278134
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of cellular immunologic responsiveness in the clinical management of patients with prostatic cancer. II. Effect of oestrogen, cryosurgery and transurethral resection on thymic-dependent lymphocytic blastogenesis.
    Ablin RJ; Guinan PD; Bruns GR; Sheik HI; Sadoughi N; Bush IM
    Urol Int; 1976; 31(5):383-400. PubMed ID: 1087494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum proteins in prostatic cancer VI. Reduction of the suppressive ("blocking"?) properties of serum on in vitro parameters of cell-mediated immunologic responsiveness following cryosurgery.
    Ablin RJ
    Urol Int; 1977; 32(1):65-73. PubMed ID: 70099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of cellular immunologic responsiveness in the clinical management of patients with prostatic cancer. III. Inhibition of leucocyte migration.
    Ablin RJ; Marrow C; Guinan PD; Bruns GR; Sadoughi N; John T; Bush IM
    Urol Int; 1976; 31(6):444-58. PubMed ID: 1006873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of immunoregulatory globulin (IRA) upon lymphocytes in vitro.
    Cooperband SR; Badger AM; Davis RC; Schmid K; Mannick JA
    J Immunol; 1972 Jul; 109(1):154-63. PubMed ID: 4113793
    [No Abstract]   [Full Text] [Related]  

  • 10. Blastogenesis of rhesus peripheral lymphocytes with competitive summation of PHA and ALS responses.
    Mackler BF; Amkraut AA; Wilson BJ; Malley A
    Exp Cell Res; 1972; 71(2):273-80. PubMed ID: 5045633
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of leukocyte migration by extracts of malignant prostatic tissue and correlation of degree of in vitro sensitization to clinical responsiveness in prostatic cancer patients.
    Ablin RJ; Bush IM; Bruns GR; John T; Sadoughi N; Guinan PD
    Urology; 1978 Mar; 11(3):289-92. PubMed ID: 565097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro correlates of cell-mediated immunity in the human.
    Bach JF
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:161-73. PubMed ID: 4277530
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies of a non-cytotoxic migration inhibitory factor from human leucocytes.
    Christoforetti R; Fireman P
    Nat New Biol; 1973 Feb; 241(111):219-21. PubMed ID: 4512587
    [No Abstract]   [Full Text] [Related]  

  • 14. Characterisation of human malignant melanoma cell lines. VI. Inhibition of 3H-thymidine uptake by normal stimulated lymphocytes.
    Lui VK; Dent PB; Liao SK
    Oncology; 1977; 34(6):251-4. PubMed ID: 593653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of transfer factor on lymphocyte function in anergic patients.
    Kirkpatrick CH; Rich RR; Smith TK
    J Clin Invest; 1972 Nov; 51(11):2948-58. PubMed ID: 5080419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potentiation and inhibition by autologous red cells and platelets of human lymphocyte transformation induced by pokeweed mitogen concanavalin A, mercuric chloride, antigen, and mixed leucocyte culture.
    Yachnin S
    Clin Exp Immunol; 1972 May; 11(1):109-24. PubMed ID: 5038768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further evaluation of the effect of estrogen on tumor-associated immunity in prostatic cancer.
    Ablin RJ; Bhatti RA; Guinan PD
    Isr J Med Sci; 1979 Jan; 15(1):9-11. PubMed ID: 422345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on in vitro models of cellular immunity.
    Shacks SJ; Granger GA
    J Reticuloendothel Soc; 1971 Jul; 10(1):28-49. PubMed ID: 5121178
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of cellular immunologic responsiveness in the clinical management of patients with prostatic cancer. I. Thymic-dependent lymphocytic blastogenesis.
    Ablin RJ; Bruns GR; Guinan PD; Bush IM
    Urol Int; 1976; 31(5):374-82. PubMed ID: 64009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective cell-mediated immunity in carcinoma of the prostate.
    Thomas JW; Jerkins G; Cox C; Lieberman P
    Invest Urol; 1976 Jul; 14(1):72-5. PubMed ID: 60303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.